|
|
|
Home > Information for Physicians > Gastroenterology & GI Endoscopy > Research Initiatives
Research Initiatives
Active Studies
- Use of novel molecular markers in the assessment of malignant potential in clinically lower risk lesions
- Retrospective review in small low risk lesions
- Use of measurement of DNA quality/quantity/presence of K-ras mutations/LOH
- Role of EUS based surveillance strategies
- Retrospective review of 10 years of experience with EUS of pancreatic cystic lesions
- IRB approved protocol to establish comprehensive database
- Prospective database of EUS surveillance and cyst fluid bank
- Use of genetic and epigenetic markers
Clinical Questions
- Molecular diagnostic tools for indeterminate lesions
- Molecular treatment of pancreatic cancer
- Optimize stent strategy for neoadjuvant patients through quality of life and cost analysis
- Improving cyst surveillance strategies
- Impact of molecular medicine including (RedPATH)
- Role of injectable therapeutics
|
|
| |
REFERRING PHYSICIAN
If you plan to refer a patient to the Pancreas Center, please fill out our contact form so we know how best to communicate with you.
> Referring Physician Contact Form
THE PANCREAS CENTER MAP
Herbert Irving Pavilion, 8th Floor
161 Fort Washington Ave,
New York, NY 10032
OUR SPECIALISTS
Pancreas Center patients have access to a highly experienced, multi-disciplinary team of gastroentorologists, oncologists, surgeons, radiologists, nurse practitioners, geneticists, genetic counselors and nutritionists.
CLINICAL TRIALS
You can play a more active role in your own health care, gain access to innovative therapies before they become widely available, and help others by contributing to advancements in medical research by participating in clinical trials.
|
|
|
